ABGclients / Chemistry & Materials / Pharma

Prous Institute for Biomedical Research: driving biomedical research in fragile X syndrome and other areas of the central nervous system

Biomedical research has never before been bestowed with such a promising future. The combination of science and technology has expanded the horizon of therapeutic innovation and become a great ray…

Comments Off on Prous Institute for Biomedical Research: driving biomedical research in fragile X syndrome and other areas of the central nervous system
18/11/2020
Prous Institute for Biomedical Research: driving biomedical research in fragile X syndrome and other areas of the central nervous system
ABGteam / Biotechnology & Life Sciences / Chemistry & Materials / Engineering & Physic / Information & Communications Technology (ICT) / Legal & Litigation / Pharma / Trademarks

Managing IP recognises the ABG IP team and includes 3 Rising Stars in its rankings

The prestigious publication Managing IP has selected Marta Rodríguez, Sofia Petterson and Iain McGeoch as Rising Stars in its final issue of 2020/21. This distinction recognises "some of the best…

Comments Off on Managing IP recognises the ABG IP team and includes 3 Rising Stars in its rankings
27/10/2020
Managing IP recognises the ABG IP team and includes 3 Rising Stars in its rankings
ABGteam / Chemistry & Materials / Pharma

Juan Arias at the International Association for the Protection of Intellectual Property (AIPPI) World Congress

Juan Arias, Managing Partner of ABG Intellectual Property, was the European representative at the Panel Session “The Coronavirus Pandemic and Its Impact on Pharma Patent Prosecution Issues, Including Patent Prosecution…

Comments Off on Juan Arias at the International Association for the Protection of Intellectual Property (AIPPI) World Congress
13/10/2020
Juan Arias at the International Association for the Protection of Intellectual Property (AIPPI) World Congress
ABGconcepts / Biotechnology & Life Sciences / Chemistry & Materials / Engineering & Physic / Information & Communications Technology (ICT) / Pharma

Protecting inventions by patent in multiple countries

Unfortunately “worldwide patents” do not exist In today’s global market, a product may be designed in one country, manufactured in another or several different locations and ultimately commercialised all over…

Comments Off on Protecting inventions by patent in multiple countries
07/07/2020
Protecting inventions by patent in multiple countries
ABGteam / Biotechnology & Life Sciences / Chemistry & Materials / Engineering & Physic / Highlight / Information & Communications Technology (ICT) / Pharma

Financial Times ranks ABG IP in the top 10 of Europe’s Leading Patent Law Firms

For the second year in a row, Financial Times has ranked us in its "Europe's Leading Patent Law Firms" ranking that was published today. This year ABG Intellectual Property figures…

Comments Off on Financial Times ranks ABG IP in the top 10 of Europe’s Leading Patent Law Firms
18/06/2020
Financial Times ranks ABG IP in the top 10 of Europe’s Leading Patent Law Firms
ABGconcepts / Biotechnology & Life Sciences / Chemistry & Materials / Engineering & Physic / Information & Communications Technology (ICT) / Pharma

What you should know on the right of priority for patents. A european perspective

Patents and their territorial scope. The Paris Convention. Patents and utility models have a limited geographical scope, i.e. a patent granted in one country has no effect beyond the territorial…

Comments Off on What you should know on the right of priority for patents. A european perspective
14/04/2020
What you should know on the right of priority for patents. A european perspective
Older Posts